Related Experiment Video
Updated: Jun 22, 2026

Inducing Meningococcal Meningitis Serogroup C in Mice via Intracisternal Delivery
Published on: November 5, 2019
Mechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development
Helena Lo1, Christoph M Tang, Rachel M Exley
1Centre for Molecular Microbiology and Infection, Department of Microbiology, Imperial College London, London, UK.
Abstract:
Neisseria meningitidis remains an important cause of severe sepsis and meningitis worldwide. The bacterium is only found in human hosts, and so must continually coexist with the immune system. Consequently, N meningitidis uses multiple mechanisms to avoid being killed by antimicrobial proteins, phagocytes, and, crucially, the complement system. Much remains to be learnt about the strategies N meningitidis employs to evade aspects of immune killing, including mimicry of host molecules by bacterial structures such as capsule and lipopolysaccharide, which poses substantial problems for vaccine design. To date, available vaccines only protect individuals against subsets of meningococcal strains. However, two promising vaccines are currently being assessed in clinical trials and appear to offer good prospects for an effective means of protecting individuals against endemic serogroup B disease, which has proven to be a major challenge in vaccine research.
Insights
Neisseria meningitidis causes severe sepsis and meningitis by evading the human immune system. New vaccines show promise for preventing serogroup B disease, a significant challenge in meningococcal vaccine development.
Area of Science:
- Immunology
- Microbiology
- Vaccinology
Background:
- Neisseria meningitidis is a significant global cause of sepsis and meningitis.
- This bacterium continuously interacts with the human immune system, employing various evasion strategies.
- Existing vaccines offer protection only against specific meningococcal strains.
Purpose of the Study:
- To understand the immune evasion mechanisms of Neisseria meningitidis.
- To address challenges in designing vaccines against meningococcal serogroup B.
- To evaluate the potential of novel vaccines against endemic serogroup B disease.
Main Methods:
- The study reviews bacterial immune evasion strategies, including molecular mimicry by capsule and lipopolysaccharide.
- It examines the limitations of current meningococcal vaccines.
- It discusses ongoing clinical trials for new vaccine candidates.
Main Results:
- Neisseria meningitidis utilizes mechanisms like molecular mimicry to evade immune responses.
- Current vaccines do not cover all meningococcal strains, particularly serogroup B.
- Promising new vaccines are in clinical trials for serogroup B disease.
Conclusions:
- Further research into Neisseria meningitidis immune evasion is crucial.
- Developing effective vaccines against serogroup B remains a priority.
- Emerging vaccines offer hope for controlling endemic serogroup B meningococcal disease.
Related Concept Videos
Bacterial Meningitis II: Pathophysiology
Colonisation of Pathogens
Defense Against Bacterial Pathogens
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
Bacterial Meningitis
Vaccines
Determinants of Bacterial Pathogenicity and Virulence

